BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
QuintilesIMS
Harvard Business School
Johnson and Johnson
Cipla
Merck
Daiichi Sankyo
Novartis
UBS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065106

« Back to Dashboard

NDA 065106 describes NEOMYCIN AND POLYMYXIN B SULFATE, which is a drug marketed by Watson Labs, X Gen Pharms, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Alcon Pharms Ltd, Amring Pharms, Ipharm, and Sandoz Inc, and is included in twenty-one NDAs. It is available from two suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATE profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATE is bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 065106
Tradename:NEOMYCIN AND POLYMYXIN B SULFATE
Applicant:X Gen Pharms
Ingredient:neomycin sulfate; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 065106
Suppliers and Packaging for NDA: 065106
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 065106 ANDA X-GEN Pharmaceuticals, Inc. 39822-1201 39822-1201-5 50 AMPULE in 1 CARTON (39822-1201-5) > 1 mL in 1 AMPULE
NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 065106 ANDA X-GEN Pharmaceuticals, Inc. 39822-1201 39822-1201-2 10 AMPULE in 1 CARTON (39822-1201-2) > 1 mL in 1 AMPULE (39822-1201-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IRRIGATIONStrengthEQ 40MG BASE/ML;200,000 UNITS/ML
Approval Date:Jan 31, 2006TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Johnson and Johnson
Chubb
Accenture
Dow
Harvard Business School
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot